Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


06.02.2017

1 Arch Pediatr
5 Arch Virol
1 BMJ
1 Indian Pediatr
1 J Immunol
3 J Virol
1 Lancet
2 Lancet Glob Health
3 Lancet Infect Dis
1 Lancet Respir Med
1 MMWR Morb Mortal Wkly Rep
1 N Engl J Med
2 Pediatr Infect Dis J
4 PLoS One
7 Vaccine
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Arch Pediatr

  1. BROUARD J, Tran L, Flammang A, Dupont C, et al
    [Influenza vaccination in children: Inactivated vaccines or live attenuated vaccines?]
    Arch Pediatr. 2017 Jan 25. pii: S0929-693X(16)30611.
    PubMed     Text format    


    Arch Virol

  2. SVIBEN D, Forcic D, Kurtovic T, Halassy B, et al
    Stability, biophysical properties and effect of ultracentrifugation and diafiltration on measles virus and mumps virus.
    Arch Virol. 2016;161:1455-67.
    PubMed     Text format     Abstract available

  3. TEWAWONG N, Chansaenroj J, Klinfueng S, Vichiwattana P, et al
    Lineage-specific detection of influenza B virus using real-time polymerase chain reaction with melting curve analysis.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available

  4. BALL C, Forrester A, Ganapathy K
    Detection of variant infectious bronchitis viruses in Sri Lanka (2012-2015).
    Arch Virol. 2016;161:1697-9.
    PubMed     Text format     Abstract available

  5. ZHU Y, Wang GH, Cui YD, Cui SJ, et al
    Establishment of a nanoparticle-assisted RT-PCR assay to distinguish field strains and attenuated strains of porcine epidemic diarrhea virus.
    Arch Virol. 2016;161:2543-7.
    PubMed     Text format     Abstract available

  6. GE F, Li X, Ju H, Yang D, et al
    Genotypic evolution and antigenicity of H9N2 influenza viruses in Shanghai, China.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    BMJ

  7. DHILLON RS, Srikrishna D, Jha AK
    Containing Zika while we wait for a vaccine.
    BMJ. 2017;356:j379.
    PubMed     Text format    


    Indian Pediatr

  8. SHASHIDHAR A
    Hexavalent Vaccinations: The Future of Routine Immunization?
    Indian Pediatr. 2017;54:11-13.
    PubMed     Text format    


    J Immunol

  9. DE ARMAS LR, Cotugno N, Pallikkuth S, Pan L, et al
    Induction of IL21 in Peripheral T Follicular Helper Cells Is an Indicator of Influenza Vaccine Response in a Previously Vaccinated HIV-Infected Pediatric Cohort.
    J Immunol. 2017 Jan 27. pii: 1601425. doi: 10.4049/jimmunol.1601425.
    PubMed     Text format     Abstract available


    J Virol

  10. NASAR F, Matassov D, Seymour RL, Latham T, et al
    Recombinant Isfahan virus and vesicular stomatitis virus vaccine vectors provide durable, multivalent, single dose protection against lethal alphavirus challenge.
    J Virol. 2017 Feb 1. pii: JVI.01729-16. doi: 10.1128/JVI.01729.
    PubMed     Text format     Abstract available

  11. HALEY SL, Tzvetkov EP, Meuwissen S, Plummer JR, et al
    Targeting Vaccine-induced Extrafollicular Pathway of B cell Differentiation Improves Rabies Post-exposure Prophylaxis.
    J Virol. 2017 Feb 1. pii: JVI.02435-16. doi: 10.1128/JVI.02435.
    PubMed     Text format     Abstract available

  12. SCHNEIDER-OHRUM K, Cayatte C, Snell Bennett A, Manohar Rajani G, et al
    Immunization with low doses of recombinant post-fusion or pre-fusion RSV F primes for vaccine-enhanced disease in the cotton rat model independent of the presence of a Th1-biasing (GLA-SE) or Th2-biasing (Alum) adjuvant.
    J Virol. 2017 Feb 1. pii: JVI.02180-16. doi: 10.1128/JVI.02180.
    PubMed     Text format     Abstract available


    Lancet

  13. CLINTON C, Sridhar D
    Who pays for cooperation in global health? A comparative analysis of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria, and Gavi, the Vaccine Alliance.
    Lancet. 2017 Jan 27. pii: S0140-6736(16)32402.
    PubMed     Text format     Abstract available


    Lancet Glob Health

  14. COHEN R, Levy C
    13-valent pneumococcal conjugate vaccine in Africa.
    Lancet Glob Health. 2017 Jan 27. pii: S2214-109X(17)30044.
    PubMed     Text format    

  15. COHEN C, von Mollendorf C, de Gouveia L, Lengana S, et al
    Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South African children: a case-control study.
    Lancet Glob Health. 2017 Jan 27. pii: S2214-109X(17)30043.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  16. SMITH J
    When free is not fair: the case of vaccine donations.
    Lancet Infect Dis. 2017;17:128-130.
    PubMed     Text format    

  17. KHAN MU, Ahmad A
    Availability and affordability of life-saving vaccines.
    Lancet Infect Dis. 2017;17:136-137.
    PubMed     Text format    

  18. KIRBY T
    Lynn Morris: the continuing quest for an HIV vaccine.
    Lancet Infect Dis. 2017;17:150.
    PubMed     Text format    


    Lancet Respir Med

  19. FURLOW B
    US authorities discourage use of nasal influenza vaccine, citing ineffectiveness.
    Lancet Respir Med. 2017;5:105-106.
    PubMed     Text format    


    MMWR Morb Mortal Wkly Rep

  20. MARLOW MA, Pambasange MA, Francisco C, Receado OD, et al
    Notes from the Field: Knowledge, Attitudes, and Practices Regarding Yellow Fever Vaccination Among Men During an Outbreak - Luanda, Angola, 2016.
    MMWR Morb Mortal Wkly Rep. 2017;66:117-118.
    PubMed     Text format    


    N Engl J Med

  21. ROSENBLATT M
    The Large Pharmaceutical Company Perspective.
    N Engl J Med. 2017;376:52-60.
    PubMed     Text format    


    Pediatr Infect Dis J

  22. MARTINON-TORRES F, Dionne M, Greenberg D, Varman M, et al
    Safety, Tolerability, and Immunogenicity of Pentavalent Rotavirus Vaccine Manufactured by a Modified Process.
    Pediatr Infect Dis J. 2017 Jan 27. doi: 10.1097/INF.0000000000001511.
    PubMed     Text format     Abstract available

  23. PINTO M, Dawar M, Krajden M, Naus M, et al
    Will Infant Hepatitis B Vaccination Protect into Adulthood? Extended Canadian Experience After a 2, 4, 6 Month Immunization Schedule.
    Pediatr Infect Dis J. 2017 Jan 26. doi: 10.1097/INF.0000000000001543.
    PubMed     Text format     Abstract available


    PLoS One

  24. ZHANG X, Mu Y, Mu P, Ao J, et al
    Transcriptome Analysis Reveals Comprehensive Insights into the Early Immune Response of Large Yellow Croaker (Larimichthys crocea) Induced by Trivalent Bacterial Vaccine.
    PLoS One. 2017;12:e0170958.
    PubMed     Text format     Abstract available

  25. CILVETI R, Olmo M, Perez-Jove J, Picazo JJ, et al
    Epidemiology of Otitis Media with Spontaneous Perforation of the Tympanic Membrane in Young Children and Association with Bacterial Nasopharyngeal Carriage, Recurrences and Pneumococcal Vaccination in Catalonia, Spain - The Prospective HERMES Study.
    PLoS One. 2017;12:e0170316.
    PubMed     Text format     Abstract available

  26. ELAISH M, Ngunjiri JM, Ali A, Xia M, et al
    Supplementation of inactivated influenza vaccine with norovirus P particle-M2e chimeric vaccine enhances protection against heterologous virus challenge in chickens.
    PLoS One. 2017;12:e0171174.
    PubMed     Text format     Abstract available

  27. ZHANG A, Lai H, Xu J, Huang W, et al
    Evaluation of the Protective Efficacy of Poly I:C as an Adjuvant for H9N2 Subtype Avian Influenza Inactivated Vaccine and Its Mechanism of Action in Ducks.
    PLoS One. 2017;12:e0170681.
    PubMed     Text format     Abstract available


    Vaccine

  28. HUANG Y, Zhang L, Janes H, Frahm N, et al
    Predictors of durable immune responses six months after the last vaccination in preventive HIV vaccine trials.
    Vaccine. 2017 Jan 25. pii: S0264-410X(16)30879.
    PubMed     Text format     Abstract available

  29. ALAN H, Ian B, Nancy C, Ruben O D, et al
    Improving the selection and development of influenza vaccine viruses - Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18-20 November 2015.
    Vaccine. 2017 Jan 25. pii: S0264-410X(17)30037.
    PubMed     Text format     Abstract available

  30. HOONAKKER ME, Verhagen LM, van der Maas L, Sloots A, et al
    Reporter cell lines for detection of pertussis toxin in acellular pertussis vaccines as a functional animal-free alternative to the in vivo histamine sensitization test.
    Vaccine. 2017 Jan 24. pii: S0264-410X(17)30016.
    PubMed     Text format     Abstract available

  31. BENN CS, Jacobsen LH, Fisker AB, Rodrigues A, et al
    Campaigns with oral polio vaccine may lower mortality and create unexpected results.
    Vaccine. 2017 Jan 27. pii: S0264-410X(16)31035.
    PubMed     Text format     Abstract available

  32. SUTCLIFFE K, Kilgore PE, DeHoff K, Evans R, et al
    Survey of vaccination knowledge and acceptance among adults admitted to an urban emergency department.
    Vaccine. 2017 Jan 28. pii: S0264-410X(17)30031.
    PubMed     Text format     Abstract available

  33. BEGIER E, Seiden DJ, Patton M, Zito E, et al
    SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies.
    Vaccine. 2017 Jan 28. pii: S0264-410X(17)30043.
    PubMed     Text format     Abstract available

  34. ZHOU J, Li S, Wang X, Zou M, et al
    Bartha-k61 vaccine protects growing pigs against challenge with an emerging variant pseudorabies virus.
    Vaccine. 2017 Jan 25. pii: S0264-410X(17)30005.
    PubMed     Text format     Abstract available


    Virology

  35. PEETERS B, Reemers S, Dortmans J, de Vries E, et al
    Genetic versus antigenic differences among highly pathogenic H5N1 avian influenza A viruses: Consequences for vaccine strain selection.
    Virology. 2017;503:83-93.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: